Topic: Float Research Collective

Dr. Justin Feinstein details findings from NIH-funded clinical trials regarding the safety and efficacy of floating for patients with severe mental health issues. Results indicate a significant reduction in muscle tension and a 14-point drop on the Spielberger state anxiety inventory after a single session. The Float Research Collective was established to advocate for insurance coverage of this therapy to make it accessible to vulnerable populations.

Dr. Feinstein outlines an ambitious goal to conduct head-to-head clinical trials comparing a single float session to a single dose of Xanax or Oxycodone. He argues that the medical establishment relies on pills because no one has funded rigorous behavioral intervention studies to prove alternatives are equally effective. The Float Research Collective is currently fundraising to challenge the pharmaceutical industry's dominance in psychiatry.